Related Experiment Video
Updated: May 18, 2026

Detection of Protein Ubiquitination
Published on: August 19, 2009
Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1
Rebecca L Foy1, Vipul C Chitalia, Maria V Panchenko
1Renal Section, Boston University Medical Center, Boston, MA 02118, USA.
Abstract:
Autosomal-dominant polycystic kidney disease (ADPKD) and von Hippel-Lindau (VHL) disease lead to large kidney cysts that share pathogenetic features. The polycystin-1 (PC1) and pVHL proteins may therefore participate in the same key signaling pathways. Jade-1 is a pro-apoptotic and growth suppressive ubiquitin ligase for beta-catenin and transcriptional coactivator associated with histone acetyltransferase activity that is stabilized by pVHL in a manner that correlates with risk of VHL renal disease. Thus, a relationship between Jade-1 and PC1 was sought. Full-length PC1 bound, stabilized and colocalized with Jade-1 and inhibited Jade-1 ubiquitination. In contrast, the cytoplasmic tail or the naturally occurring C-terminal fragment of PC1 (PC1-CTF) promoted Jade-1 ubiquitination and degradation, suggesting a dominant-negative mechanism. ADPKD-associated PC1 mutants failed to regulate Jade-1, indicating a potential disease link. Jade-1 ubiquitination was mediated by Siah-1, an E3 ligase that binds PC1. By controlling Jade-1 abundance, PC1 and the PC1-CTF differentially regulate Jade-1-mediated transcriptional activity. A key target of PC1, the cyclin-dependent kinase inhibitor p21, is also up-regulated by Jade-1. Through Jade-1, PC1 and PC1 cleaved forms may exert fine control of beta-catenin and canonical Wnt signaling, a critical pathway in cystic renal disease. Thus, Jade-1 is a transcription factor and ubiquitin ligase whose activity is regulated by PC1 in a manner that is physiologic and may correlate with disease. Jade-1 may be an important therapeutic target in renal cystogenesis.
Insights
Autosomal-dominant polycystic kidney disease (ADPKD) and von Hippel-Lindau (VHL) disease involve kidney cysts. Researchers found polycystin-1 (PC1) regulates Jade-1, a protein linked to cyst formation, suggesting a therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Autosomal-dominant polycystic kidney disease (ADPKD) and von Hippel-Lindau (VHL) disease are genetic disorders characterized by the development of large kidney cysts.
- Both diseases share common pathogenetic features, suggesting that key proteins like polycystin-1 (PC1) and pVHL may be involved in similar signaling pathways.
- Jade-1, a ubiquitin ligase, acts as a growth suppressor and is stabilized by pVHL, with its regulation by pVHL correlating with VHL renal disease risk.
Purpose of the Study:
- To investigate the potential relationship between Jade-1 and PC1 in the context of kidney cyst formation.
- To elucidate the mechanism by which PC1 and its fragments regulate Jade-1 activity and stability.
- To explore the implications of PC1-Jade-1 interactions in ADPKD and VHL disease pathogenesis.
Main Methods:
- Co-immunoprecipitation assays to assess binding between PC1 and Jade-1.
- Western blotting to evaluate protein stability and ubiquitination levels.
- Analysis of PC1 mutants associated with ADPKD to determine their effect on Jade-1 regulation.
- Luciferase reporter assays to measure Jade-1-mediated transcriptional activity.
Main Results:
- Full-length PC1 binds to, stabilizes, and colocalizes with Jade-1, inhibiting its ubiquitination.
- The C-terminal fragment of PC1 (PC1-CTF) promotes Jade-1 ubiquitination and degradation, indicating a dominant-negative effect.
- ADPKD-associated PC1 mutants exhibit impaired regulation of Jade-1.
- Jade-1 ubiquitination is mediated by Siah-1, an E3 ligase that also binds PC1.
- PC1 and PC1-CTF differentially regulate Jade-1's transcriptional activity, impacting downstream targets like p21.
Conclusions:
- Jade-1 is a key regulator of beta-catenin and canonical Wnt signaling, pathways critical in cystic renal diseases.
- PC1 and its cleaved forms exert fine control over Jade-1 abundance and activity, influencing renal cystogenesis.
- Jade-1 represents a potential therapeutic target for managing kidney cyst development in ADPKD and VHL disease.
More Related Videos
11:33Investigating Interactions Between Histone Modifying Enzymes and Transcription Factors in vivo by Fluorescence Resonance Energy Transfer
Published on: October 14, 2022
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Regulation of Expression at Multiple Steps
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Master Transcription Regulators
Master Transcription Regulators
Abnormal Proliferation